Targadox is a U.S. brand of doxycycline hyclate 50 mg film-coated tablets. Its official label identifies a specific oral tablet product and package records, making it a distinct product-search entity rather than an umbrella name for doxycycline 50 mg capsules, monohydrate formulations or modified-release products.
A user encountering Targadox may be reading an old prescription, researching a brand name or comparing it with a generic 50 mg listing. The key question is whether the full prescribed product—hyclate tablet, 50 mg, appropriate formulation—matches the pharmacy offering. A manufacturer’s label does not itself confirm availability or pricing.
This page focuses on Targadox as a brand. For all 50 mg forms, including different salts, use the cross-brand 50 mg guide; for the wider salt category use the doxycycline hyclate overview.
U.S. DailyMed labeling describes Targadox as doxycycline hyclate tablets equivalent to 50 mg of doxycycline. It gives a recognizable product record separate from generic monohydrate capsules.
If a pharmacy site abbreviates the product name to “doxycycline 50,” that is not enough to establish it is Targadox or a suitable substitution. Ask for the dosage form and salt explicitly.
A brand tablet strength is a commercial product identifier. It does not indicate that doxycycline is appropriate for any specific patient complaint or establish a standard frequency or duration.
Doxycycline is an antibacterial medicine when used for appropriate susceptible infections and other specific labeled circumstances. Medical diagnosis, allergies, precautions and the prescriber’s plan remain essential.
Monodox 50 mg refers to a doxycycline monohydrate capsule, while Targadox 50 mg is a doxycycline hyclate tablet. They share an active moiety and printed strength but are distinct labeled presentations.
The distinction affects any proposed generic or brand selection. See Monodox capsule labeling for the other product family rather than treating both as one 50 mg brand.
This table distinguishes product names, not recommended substitutions.
| Item in search results | Product classification | What to verify |
|---|---|---|
| Targadox 50 mg | Branded hyclate film-coated tablet | Label and actual pharmacy supply |
| Generic doxycycline hyclate 50 mg tablet | Potential similar salt/form category | Specific approved product and substitution |
| Monodox 50 mg | Monohydrate capsule | Different salt and dosage form |
| Other branded doxycycline tablet | May be a different strength or release design | No brand-name interchange assumption |
The current DailyMed Targadox labeling describes a light-beige, round, film-coated 50 mg tablet bearing the "J" and "050" debossing, and lists five-tablet (NDC 69489-111-05) and sixty-tablet (NDC 69489-111-60) bottle presentations. These published identifiers are useful when a pharmacist checks a branded order or questions a look-alike listing.
The label and NDC identify specified product/package records, not live pharmacy inventory. The exact bottle that can be supplied, substitution status and current price still require confirmation with the licensed dispensing pharmacy.
A generic doxycycline hyclate 50 mg tablet may be considered if it meets applicable regulatory equivalence and the prescribed product specification. A pharmacist should confirm the exact approved item and applicable substitution rules.
Do not infer generic equivalence simply because another product says 50 mg or shares a similar tablet color. This page does not recommend switching from Targadox to a monohydrate capsule or delayed-release tablet.
For any current quote, confirm the actual dispensed product, number of tablets, cash or insurance method and whether a particular discount applies. Price information should be checked directly with the pharmacy rather than copied from undated online listings.
For the end-to-end U.S. prescription process use the buying guide. Targadox itself remains the specific product under discussion here.
Doxycycline can cause adverse effects and interactions that are not eliminated by the 50 mg label. Targadox labeling warns about photosensitivity, esophageal irritation and rare severe skin reactions, including Stevens–Johnson syndrome, toxic epidermal necrolysis and DRESS. New blistering, peeling, mucosal sores or a widespread painful rash require urgent assessment; the label directs immediate discontinuation if a severe skin reaction occurs. A pharmacist should also review adequate water intake, other medicines and supplements, and product-specific instructions.
If a current bottle differs from the previous Targadox name or appearance, verify the proposed replacement and directions before taking the medicine. Brand familiarity is not a substitute for correct dispensing.
A U.S. branded doxycycline hyclate 50 mg oral tablet product.
No. The official Targadox tablet label identifies doxycycline hyclate.
No. Monodox is a monohydrate capsule brand, while Targadox is a 50 mg hyclate tablet.
A pharmacist must confirm the exact appropriate approved generic and applicable substitution rules.
Yes. The referenced Targadox U.S. label describes 50 mg film-coated tablets.
No. Current supply and cost require direct pharmacy verification.
No. It is a U.S. prescription drug and should be used only for an appropriate clinician-determined purpose.